Uaprasert N, Pitakkitnukun P, Tangcheewinsirikul N, Chiasakul T, Rojnuckarin P. Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis. Blood Cancer J 2022;12:173. [PMID: 36550105 DOI: 10.1038/s41408-022-00776-5][Reference Citation Analysis]
2
Wang L, Wang W, Xu R, Berger NA. SARS-CoV-2 primary and breakthrough infections in patients with cancer: Implications for patient care. Best Pract Res Clin Haematol 2022;35:101384. [PMID: 36494154 DOI: 10.1016/j.beha.2022.101384][Reference Citation Analysis]